VITAL LABORATORIES PRIVATE LIMITED
VITAL LABORATORIES PRIVATE LIMITED is a drug establishment in Vapi, India, registered with the US FDA under FEI 3007474872. Its registered operations are: Analytical testing, API manufacture. No EU or UK GMP certificate is matched to this site in our data; that is not evidence it has none. FDA has published 3 inspection outcomes for this FEI; the most recent, ended 1 Sept 2018, was classified official action indicated (OAI).
Sources: FDA Drug Establishments Current Registration Site (checked 16 Nov 2026); FDA Data Dashboard (inspections); EudraGMDP; MHRA GMDP. Methodology
Cite as: PharmaTek, “VITAL LABORATORIES PRIVATE LIMITED: FDA registration, inspection and GMP record (FEI 3007474872)”, record as of 16 Nov 2026, pharmatek.co.uk/manufacturing-sites/vital-laboratories-private-limited-vapi-3007474872
Registered operations
Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.
GMP documents matched to this site (0)
No EU or UK GMP document is matched to this site. Sites are matched by name and address, so an unmatched site may still hold a certificate; ask the company for it.
A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.
FDA inspection outcomes (3)
| Inspection ended | Outcome | Programme area | Citations posted |
|---|---|---|---|
| 1 Sept 2018 | OAI · Official action indicated | Drug Quality Assurance | No |
| 6 Apr 2017 | OAI · Official action indicated | Drug Quality Assurance | No |
| 25 Oct 2013 | VAI · Voluntary action indicated | Drug Quality Assurance | No |
FDA Data Dashboard, joined on the FEI. NAI: no objectionable conditions found. VAI: objectionable conditions found, but not serious enough for regulatory action. OAI: regulatory or administrative action recommended. A classification describes one inspection on one date; FDA publishes it only once final and does not publish every inspection. FDA firm profile
FDA warning letters (1)
- Warning letter issued 11 Oct 2017FDA warning letters
FDA Data Dashboard, drug products, issued against FEI 3007474872. A warning letter may since have been closed out; FDA publishes close-out letters separately.
What this page does not show
- Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
- Capacity, scale, price or current availability: no regulator publishes these.
- The full text of a Form 483 or warning letter: FDA's dashboard gives the regulation cited and a short description only.
Is this Vital Laboratories Private Limited?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.